Navigation Links
VaxGen in Medical News

FDA Warns VaxGen On Anthrax Vaccine

The Food and Drug Administration has warned the manufacturers of a new vaccine for anthrax for making false claims about the purity and effectiveness// of the vaccine. VaxGen Inc was accused of inflating the claims based on a few studies, the data for which is not enough for issuing such statements...

VaxGen Provides Financial Update Following the Filing of Its 10-Q for Second Quarter With SEC; Results Include $8.5 Million Charge in Respect of Manufacturing Plant Asset Impairment

...w.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO ) vaxgen had approximately $59 million in cash and equivale...any's $30 million of outstanding convertible debt. vaxgen reported a net loss for the second quarter of $10....agreed to terms, for reasons entirely unrelated to vaxgen or the plant. In light of this, however, our expec...

New HIV browser gives researchers access to valuable data from vaccine trials

...raphic and clinical data from volunteers who became HIV infected during the vaxgen clinical trial. The browser allows users to align viral sequences with one ...quence data from infected participants in the Phase III clinical trial that vaxgen conducted in Thailand. "In the future, the database will be expanded to...

VaxGen Restructures Following Termination of Proposed Merger

...ger between VaxGen and Raven biotechnologies, inc. vaxgen has moved to terminate the staff which it had reta...n of the needs of the merged company. As a result, vaxgen will be terminating approximately 75% of its remai...91112/VAXGENLOGO ) "It is quite unfortunate that vaxgen must now terminate so many of our most capable and...

VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven

.../ -- VaxGen Inc. (OTC Bulletin Board: VXGN) Dear vaxgen Stockholder, March 28th marks the date of the Sp...cial Stockholder meeting and the conclusion of the vaxgen stockholder vote on the proposed VaxGen-Raven merg...ity of the votes cast in person or by proxy at the vaxgen special meeting is required for approval of the me...

VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement

...sed Transaction Under the terms of the agreement, vaxgen shall issue, and the holders of Raven Series D pre...ee transaction, approximately 32 million shares of vaxgen common stock. Following the closing of the transaction, vaxgen stockholders will own approximately 51 percent of ...

An alternative vaccine to combat Anthrax

...e using this data to help design strategies for testing of this vaccine in the future." Gorse indicated that the investigational vaccine, made by vaxgen Inc., demonstrated a clear relationship between the amount of vaccine administered and the subsequent immune response. The study was designed to e...

Two AIDS Vaccine Trials Hold Hope Against Epidemic

...n South America and the Caribbean, is an improvement over the disappointing vaxgen that came to a dead end in Thailand in 2003, Koff said. Tests on the ...y miraculous," Nabel told DPA. In addition, a modified version of the vaxgen trials continues on 16,000 volunteers in Thailand, who are receiving an add...
VaxGen in Medical Technology

Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer

...therapeutic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast and ovarian cancer. On November 12, 2007, Raven and vaxgen Inc. (OTC: VXGN.PK), a biopharmaceutical company, announced that their respective boards of directors unanimously approved a definitive merger agreeme...

GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials

...ials. Only a handful of AIDS vaccines have reached the Phase 2 level of clinical evaluation with the HVTN, including the previously failed vaccines of vaxgen and Merck," stated GeoVax President, Don Hildebrand. GeoVax has completed two Phase 1 human trials evaluating its AIDS vaccines with excellent resul...

ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.

..., today announced it has finalized a Material Transfer Agreement (MTA) with vaxgen Inc. (Pink Sheets: VXGN.PK). As part of the agreement, ImmuneRegen will rec...nd, Viprovex, will demonstrate adjuvant activity in a rabbit model with the vaxgen vaccine," said Hal Siegel, Ph.D., Senior Director of Product Development an...
VaxGen in Biological News

Combating anthrax: Results of study published this month as researchers look for a better vaccine

... be using this data to help design strategies for testing of this vaccine in the future." Gorse indicated that the investigational vaccine, made by vaxgen Inc., demonstrated a clear relationship between the amount of vaccine administered and the subsequent immune response. The study was designed to ev...
VaxGen in Biological Technology

VaxGen Restructures Board of Directors

.../VAXGENLOGO ) In conjunction with these changes, vaxgen is reconstituting the Strategic Transactions Commi...logy transaction experience." said James P. Panek, vaxgen President and CEO. "I am delighted to welcome two ...ice over the past several years." About VaxGen vaxgen is a biopharmaceutical company based in South San ...

Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance

... recent restructuring undertaken on April 9, 2008. vaxgen expects that its average monthly cash expenditures... the Company's sole control," said James P. Panek, vaxgen President and CEO. "While we continue to explore e...ovide assurance that a transaction will result." vaxgen further announced today the filing of its financia...

VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.

...rms of the transaction, Emergent BioSolutions paid vaxgen $2 million upon execution of the definitive agreem...of returns for our shareholders." About VaxGen vaxgen is a biopharmaceutical company based in South San ...ts that speak only as of the date of this release. vaxgen undertakes no obligation to update publicly any fo...

VaxGen and Raven Terminate Merger Agreement

...n anticipated opposition to the proposed merger by vaxgen stockholders. In addition, VaxGen's Board has with...related equity plan proposals would be rejected by vaxgen stockholders. (Logo: http://www.newscom.com/cgi...on, such that this merger will not be approved." vaxgen intends to open the Special Meeting of Stockholder...

VaxGen Issues Rebuttal to MedCap Letter

...en would represent a fairly disastrous outcome for vaxgen and would view it as a clear signal to sell VaxGen...le are discussed in the addendum to this letter. vaxgen believes these recent communications from MedCap s...way the VaxGen-Raven merger vote any way they can. vaxgen believes this includes the use of flawed arguments...

VaxGen Common Stock Now Quoted on OTC Bulletin Board

...iegel and Company is the market maker and assisted vaxgen with the qualification process. (Logo: http://w...e closing condition to the proposed merger between vaxgen and Raven requiring that VaxGen be listed on an ap...s to vote on the proposed merger. About VaxGen vaxgen is a biopharmaceutical company based in South San ...

Raven Announces RAV12 Phase 1/2a Study Results To Be Presented at ASCO

...tic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. On November 12, 2007, Raven and vaxgen Inc. (Pink Sheets: VXGN.PK), a biopharmaceutical company, announced that their respective boards of directors unanimously approved a definitive merger...

VaxGen Reports Financial Update

...gi-bin/prnh/19991112/VAXGENLOGO ) Specifically, vaxgen announced the following: -- Cash, cash equivalent...s current best estimate of fair market value. vaxgen has not yet received an offer for the manufact...tion at this reduced value, or indeed at all. vaxgen expects to file its 2007 financial statements ...

Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations

...herapeutic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast, and ovarian cancer. On November 12, 2007, Raven and vaxgen Inc. (Pink Sheets: VXGN), a biopharmaceutical company, announced that their respective boards of directors unanimously approved a definitive merger ag...

VaxGen to Present at the 10th Annual BIO CEO and Investor Conference

...ter the live presentation. About VaxGen vaxgen is a biopharmaceutical company based in South San ...ts that speak only as of the date of this release. vaxgen and Raven undertake no obligation to update public...w. Additional Information and Where to Find It vaxgen has filed a registration statement on Form S-4, an...
Other Tags
(Date:6/30/2015)... ... June 30, 2015 , ... James C. ... & Sarcoma surgery at HackensackUMC and Director of the Skin and Sarcoma division ... distribution of his online Orthopedic Oncology and Pathology Course. The newly installed ...
(Date:6/30/2015)... ... 30, 2015 , ... Tulika Ranjan, MD, a prominent neuro-oncologist ... (AHN) as Director of its Adult Neuro-Oncology program. , Dr. Ranjan’s ... leptomeningeal disease and the neurological complications of cancer. She has special expertise ...
(Date:6/30/2015)... ... 30, 2015 , ... Eldermark Software shakes up the industry ... care sector. As an innovator of senior care software products, Eldermark ... and offer residents better care. , This next-generation interactive system handles all communications ...
(Date:6/30/2015)... ... June 30, 2015 , ... India Network Foundation today announced ... its visitor health insurance plans that provides coverage for visitors to the United States. ... enable visitors to obtain services from most experienced health care professional close to their ...
(Date:6/30/2015)... ... ... to today’s housing market, many people cannot afford to “down size” as they get older. ... to how to carry laundry or groceries from one level of their home to another. ... floor of the home, and the bedrooms are located on another floor. This condition ...
Breaking Medicine News(10 mins):Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 2Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 3Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 3Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 3Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 2Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 3Health News:Butler Mobility Products announce a Solution to Carry Items from One Floor to the Next with a Dumbwaiter 2
(Date:6/24/2015)... Switzerland , June 24, 2015 ... partnership with emerging biometric password solution one face ... one face in, entering ... a ground-breaking and affordable multifactor-authentication biometric answer to ... recognition technology, provided in partnership with KeyLemon, one ...
(Date:6/23/2015)... Fla. , June 23, 2015 /PRNewswire/ ... management and authentication solutions, today announced enhanced functionality ... multi-factor authentication solution.  The enhancements build on ... of the DigitalPersona Altus platform and provide ... compatibility. In today,s environment of ...
(Date:6/17/2015)... and HILDEN, Germany , June 17, 2015 ... Frankfurt Prime Standard: QIA) today launched new Investigator ® ... laboratories in the United States . The ... analyze multiple key genomic markers (short tandem repeats or STRs) ... Sensor to evaluate the quality of DNA in each sample, ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
Other Contents